Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
Cash Flows From Operating Activities | |||||
Net Income | 4,566,000 | 2,933,000 | 1,147,000 | 12,000 | 6,201,000 |
Depreciation Amortization | 2,103,000 | 1,575,000 | 1,050,000 | 525,000 | 2,050,000 |
Income taxes - deferred | -1,552,000 | -1,214,000 | -944,000 | -651,000 | -116,000 |
Accounts receivable | -406,000 | -125,000 | 247,000 | 699,000 | 313,000 |
Accounts payable and accrued liabilities | 226,000 | -38,000 | -104,000 | -91,000 | -118,000 |
Other Working Capital | -1,763,000 | -1,880,000 | -1,763,000 | -1,162,000 | 489,000 |
Other Operating Activity | 5,898,000 | 5,254,000 | 4,009,000 | 2,508,000 | 2,565,000 |
Operating Cash Flow | $9,072,000 | $6,505,000 | $3,642,000 | $1,840,000 | $11,384,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 232,000 | 204,000 | 188,000 | 12,000 | -607,000 |
PPE Investments | -728,000 | -547,000 | -390,000 | -247,000 | -579,000 |
Net Acquisitions | -1,797,000 | -1,579,000 | -1,131,000 | -807,000 | -1,584,000 |
Purchase Of Investment | -172,000 | -166,000 | -44,000 | -28,000 | -380,000 |
Other Investing Activity | -1,000 | -3,000 | -1,000 | 0 | 19,000 |
Investing Cash Flow | $-2,466,000 | $-2,091,000 | $-1,378,000 | $-1,070,000 | $-3,131,000 |
Cash Flows From Financing Activities | |||||
Debt Repayment | -1,500,000 | -1,500,000 | -500,000 | -500,000 | -4,750,000 |
Common Stock Issued | 309,000 | 133,000 | 97,000 | 94,000 | 169,000 |
Common Stock Repurchased | -1,396,000 | -604,000 | -424,000 | -352,000 | -546,000 |
Dividend Paid | -3,709,000 | -2,794,000 | -1,865,000 | -945,000 | -3,605,000 |
Other Financing Activity | -173,000 | -150,000 | -105,000 | -91,000 | -145,000 |
Financing Cash Flow | $-6,469,000 | $-4,915,000 | $-2,797,000 | $-1,794,000 | $-8,877,000 |
Exchange Rate Effect | -63,000 | -138,000 | -66,000 | -18,000 | -35,000 |
Beginning Cash Position | 5,338,000 | 5,338,000 | 5,338,000 | 5,338,000 | 5,997,000 |
End Cash Position | 5,412,000 | 4,699,000 | 4,739,000 | 4,296,000 | 5,338,000 |
Net Cash Flow | $74,000 | $-639,000 | $-599,000 | $-1,042,000 | $-659,000 |
Free Cash Flow | |||||
Operating Cash Flow | 9,072,000 | 6,505,000 | 3,642,000 | 1,840,000 | 11,384,000 |
Capital Expenditure | -728,000 | -547,000 | -390,000 | -247,000 | -579,000 |
Free Cash Flow | 8,344,000 | 5,958,000 | 3,252,000 | 1,593,000 | 10,805,000 |